1,494 reports of this reaction
2.5% of all CANDESARTAN CILEXETIL reports
#5 most reported adverse reaction
HEADACHE is the #5 most commonly reported adverse reaction for CANDESARTAN CILEXETIL, manufactured by ANI Pharmaceuticals, Inc.. There are 1,494 FDA adverse event reports linking CANDESARTAN CILEXETIL to HEADACHE. This represents approximately 2.5% of all 59,566 adverse event reports for this drug.
Patients taking CANDESARTAN CILEXETIL who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for CANDESARTAN CILEXETIL, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for CANDESARTAN CILEXETIL:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 1,494 FDA reports for CANDESARTAN CILEXETIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.5% of all adverse event reports for CANDESARTAN CILEXETIL, making it a notable side effect.
If you experience headache while taking CANDESARTAN CILEXETIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.